Literature DB >> 8473488

Vasodilator and constrictor actions of platelet-activating factor in the isolated microperfused afferent arteriole of the rabbit kidney. Role of endothelium-derived relaxing factor/nitric oxide and cyclooxygenase products.

L A Juncos1, Y L Ren, S Arima, S Ito.   

Abstract

It has been suggested that platelet-activating factor (PAF) plays a prominent role in the control of glomerular hemodynamics in various physiological and pathological conditions. We examined the direct effect of PAF on rabbit glomerular afferent arterioles (Af-Arts) microperfused in vitro and tested whether endothelium-derived relaxing factor/nitric oxide (EDNO) and cyclooxygenase products are involved in its actions. In nanomolar concentrations PAF caused dose-dependent constriction of Af-Arts, with the maximum constriction being 34 +/- 10% at 4 x 10(-8) M (n = 9, P < 0.001). The constriction was blunted by cyclooxygenase inhibition (11 +/- 6%, n = 7, P < 0.05) but augmented by EDNO inhibition (76 +/- 14%, n = 8, P < 0.005). To study a possible vasodilator effect of PAF, Af-Arts were preconstricted with norepinephrine and increasing concentrations of PAF added to the lumen. At picomolar concentrations (lower than those that caused constriction), PAF produced dose-dependent vasodilation that was unaffected by cyclooxygenase inhibition but was abolished by EDNO synthesis inhibition. Both PAF-induced constriction and dilation of Af-Arts were blocked by a PAF receptor antagonist. This study demonstrates that PAF has a receptor-mediated biphasic effect on rabbit Af-Arts, dilating them at low concentrations while constricting them at higher concentrations. Our results suggest that PAF's vasodilator action may be due to production of EDNO, while its constrictor action is mediated at least in part through cyclooxygenase products.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8473488      PMCID: PMC288109          DOI: 10.1172/JCI116339

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  35 in total

1.  Platelet-activating factor mediates endotoxin-induced acute renal insufficiency in rats.

Authors:  J Wang; M J Dunn
Journal:  Am J Physiol       Date:  1987-12

2.  Glomerular responses to platelet-activating factor in the rat: role of thromboxane A2.

Authors:  K F Badr; D K DeBoer; K Takahashi; R C Harris; A Fogo; H R Jacobson
Journal:  Am J Physiol       Date:  1989-01

Review 3.  Potential role of platelet-activating factor in renal pathophysiology.

Authors:  G Camussi
Journal:  Kidney Int       Date:  1986-02       Impact factor: 10.612

Review 4.  Perspectives in platelet-activating factor research.

Authors:  P Braquet; L Touqui; T Y Shen; B B Vargaftig
Journal:  Pharmacol Rev       Date:  1987-06       Impact factor: 25.468

5.  Vasoconstrictor effects of platelet-activating factor in the hamster cheek pouch microcirculation: dose-related relations and pathways of action.

Authors:  P K Dillon; A B Ritter; W N Durán
Journal:  Circ Res       Date:  1988-04       Impact factor: 17.367

6.  Platelet activating factor (PAF) as a mediator of injury in nephrotoxic nephritis.

Authors:  T Bertani; M Livio; D Macconi; M Morigi; G Bisogno; C Patrono; G Remuzzi
Journal:  Kidney Int       Date:  1987-06       Impact factor: 10.612

7.  Role of platelet activating factor in endotoxemic acute renal failure in the male rat.

Authors:  J P Tolins; G M Vercellotti; M Wilkowske; B Ha; H S Jacob; L Raij
Journal:  J Lab Clin Med       Date:  1989-03

8.  Platelet activating factor is a potent stimulant of the production of active oxygen species by human monocyte-derived macrophages.

Authors:  M Rouis; F Nigon; M J Chapman
Journal:  Biochem Biophys Res Commun       Date:  1988-11-15       Impact factor: 3.575

9.  Platelet-activating factor-induced homologous and heterologous desensitization in cultured vascular smooth muscle cells.

Authors:  U S Schwertschlag; A R Whorton
Journal:  J Biol Chem       Date:  1988-09-25       Impact factor: 5.157

10.  Hemodynamic effects of platelet activating factor in the dog kidney in vivo.

Authors:  H Scherf; A S Nies; U Schwertschlag; M Hughes; J G Gerber
Journal:  Hypertension       Date:  1986-09       Impact factor: 10.190

View more
  3 in total

1.  Involvement of nitric oxide and eicosanoids in platelet-activating factor-induced haemodynamic and haematological effects in dogs.

Authors:  K Noguchi; T Matsuzaki; N Shiroma; Y Ojiri; M Sakanashi
Journal:  Br J Pharmacol       Date:  1996-06       Impact factor: 8.739

2.  Cyclic guanosine monophosphate is the mediator of platelet-activating factor inhibition on transport by the mouse kidney thick ascending limb.

Authors:  F Néant; M Imbert-Teboul; C Bailly
Journal:  J Clin Invest       Date:  1994-09       Impact factor: 14.808

3.  Nuclear localization of platelet-activating factor receptor controls retinal neovascularization.

Authors:  Vikrant K Bhosle; José Carlos Rivera; Tianwei Ellen Zhou; Samy Omri; Melanie Sanchez; David Hamel; Tang Zhu; Raphael Rouget; Areej Al Rabea; Xin Hou; Isabelle Lahaie; Alfredo Ribeiro-da-Silva; Sylvain Chemtob
Journal:  Cell Discov       Date:  2016-07-12       Impact factor: 10.849

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.